Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer
Keyword(s):
2013 ◽
2020 ◽
Vol 9
(3)
◽
pp. 603-616
◽
Keyword(s):
Keyword(s):
Keyword(s):
2011 ◽
Vol 29
(15_suppl)
◽
pp. 10580-10580
◽
Keyword(s):